Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052-Reference-Cited by-同舟云学术

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052

Published:2017-05-08 Issue:5 Volume:12 Page:e0177281
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Palumbo Philip J.,Wilson Ethan A.,Piwowar-Manning Estelle,McCauley Marybeth,Gamble Theresa,Kumwenda Newton,Makhema Joseph,Kumarasamy Nagalingeswaran,Chariyalertsak Suwat,Hakim James G.,Hosseinipour Mina C.,Melo Marineide G.,Godbole Sheela V.,Pilotto Jose H.,Grinsztejn Beatriz,Panchia Ravindre,Chen Ying Q.,Cohen Myron S.,Eshleman Susan H.^ORCID,Fogel Jessica M.

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection;MM Cousins;PLoS One,2011

2. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection;R Shankarappa;J Virol,1999

3. Identifying and characterizing recently transmitted viruses;BF Keele;Curr Opin HIV AIDS,2010

4. The causes and consequences of HIV evolution;A Rambaut;Nat Rev Genet,2004

5. Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations;KM Kitrinos;J Virol,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load;PLOS Computational Biology;2023-01-03

2. Near full genome characterization of HIV‐1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns;Journal of the International AIDS Society;2019-07

3. Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B;Infection and Drug Resistance;2018-05